The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, ...

Good' (HDL) cholesterol, usually considered to be beneficial for health, may be linked to a heightened risk of the serious ...

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...

eye and kidney damage caused by type 1 diabetes researchers have found. That suggests doctors may be able to use data from the devices to help save patients from blindness, diabetic neuropathy ...

In a new study, researchers found that time-in-range for healthy blood sugar could be a viable marker of glycemic control and potentially could be used to predict complications of type 1 diabetes.

In October, Oxular began a phase 2 trial for its therapeutic candidate OXU-001, for treatment of diabetic macular edema ...

It might sound silly, but my under-eye area is where I can feel dryness the most, and eye creams and masks save my skin time and time again. As with any beauty product, there are always a few ...